by EmpathiCSubstanceS | Nov 25, 2019 | Bipolar Disorder
You can extract more than 70 different components from a cannabis plant, technically known as cannabis sativa. Two of the most common constituents are delta-9-tetrahydrocannabinol (known colloquially as THC) and cannabidiol (CBD). Because CBD is not as regulated as...
by EmpathiCSubstanceS | Nov 25, 2019 | Depression
Psilocybin, the psychoactive compound found naturally in “magic mushrooms,” has shown promising results in treating anxiety and depression. A recently published study reinforces that potential, demonstrating that depressed patients treated with psilocybin...
by EmpathiCSubstanceS | Nov 24, 2019 | Alcoholism
Supplementing psychotherapy with small doses of MDMA could be an effective strategy to prevent relapses of alcohol addiction in patients, an ongoing small clinical trial suggests. The research is yet another example of how scientists and doctors are finding or...
by EmpathiCSubstanceS | Nov 24, 2019 | Addiction
Scientists from the Johns Hopkins Psychedelic Research Unit are commencing a landmark human clinical trial to explore the effects of psilocybin in persons with chronic anorexia nervosa (AN). The new trial adds to a growing body of evidence finding psychedelic...
by EmpathiCSubstanceS | Nov 24, 2019 | Anxiety
Scientists from the Johns Hopkins Psychedelic Research Unit are commencing a landmark human clinical trial to explore the effects of psilocybin in persons with chronic anorexia nervosa (AN). The new trial adds to a growing body of evidence finding psychedelic...
